Information technologies as a tool of pharmaceutical data management
Abstract
About the Authors
K. A. KoshechkinRussian Federation
E. M. Rychikhina
Russian Federation
References
1. Treaty on the Eurasian Economic Union, Astana, May 29, 2014. Available from: https://goo.gl/lKMyOl (in Russian).
2. Draft rules for registration and analysis of medical products for human use. Available from: https://goo.gl/1Uo9T5 (in Russian).
3. Guidance for Industry, ICH M4. Organization of the CTD. U. S. Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research (CDER). Center for Biologics Evaluation and Research (CBER). August 2001.
4. Bunyatyan ND, Sakaeva IV, Kosareva TV, Korsun LV, Sakanyan VA. Comparative analysis of drug registration system in the Russian Federation and in the European Union. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2011; (2): 39–42 (in Russian).
5. U. S. FDA Signals Intent to Reject eCTDs with Technical Issues. Available from: https://goo.gl/7sstwY.
6. Clark K. Updates from the Regulators: FDA. Available from: https://goo.gl/zdiHUQ.
7. Clark K. DIA Update: News from the FDA. Available from: https://goo.gl/hN45JN.
8. Federal Law of the Russian Federation of 22.12.2014 No. 429-FZ «On Amending the Federal Law «On Circulation of Medicines» (in Russian).
9. Available from: https://goo.gl/VOzDjU (in Russian).
10. Merkulov VA, Bunyatyan ND, Koshechkin KA, Sboev GA. Current status and future development of the single information space of the FSBI «SCEMAP» of the Ministry of Health of the Russian Federation. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2013; (4): 38–41 (in Russian).
Review
For citations:
Koshechkin K.A., Rychikhina E.M. Information technologies as a tool of pharmaceutical data management. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2017;7(2):122-125. (In Russ.)